OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 76 citing articles:

Clinical applications of stem cell-derived exosomes
Fei Tan, Xuran Li, Zhao Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 235

Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment
Xue Yang, Qing Li, Wenting Liu, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 6, pp. 583-599
Open Access | Times Cited: 51

Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
Qiying Pei, Qian Yi, Liling Tang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9671-9671
Open Access | Times Cited: 50

Engineered exosome-mediated delivery of circDIDO1 inhibits gastric cancer progression via regulation of MiR-1307-3p/SOCS2 Axis
Zhen Guo, Yu Zhang, Wenrong Xu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 47

Stem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential
Pinyan Liu, Yongcui Mao, Ye Xie, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47

The potential role and mechanism of circRNA/miRNA axis in cholesterol synthesis
Wujun Chen, Jiazhen Xu, Yudong Wu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 9, pp. 2879-2896
Open Access | Times Cited: 40

Exosomes in liver fibrosis: The role of modulating hepatic stellate cells and immune cells, and prospects for clinical applications
Yufei Liu, Yuhong Zheng, Yang Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28

Current Status and Prospect of Delivery Vehicle Based on Mesenchymal Stem Cell-Derived Exosomes in Liver Diseases
Xinfeng Lu, Haijun Guo, Xuyong Wei, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 2873-2890
Open Access | Times Cited: 25

Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes
Manar A. Didamoony, Ayman A. Soubh, Lamiaa A. Ahmed
Drug Delivery and Translational Research (2025)
Open Access | Times Cited: 1

Immunomodulatory and Regenerative Effects of MSC-Derived Extracellular Vesicles to Treat Acute GVHD
Sumie Fujii, Yasuo Miura
Stem Cells (2022) Vol. 40, Iss. 11, pp. 977-990
Closed Access | Times Cited: 30

Macrophage PTEN controls STING-induced inflammation and necroptosis through NICD/NRF2 signaling in APAP-induced liver injury
Tao Yang, Xiaoye Qu, Jiaying Zhao, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 20

A review of the effect of exosomes from different cells on liver fibrosis
Xiaojie Hu, Qinglin Ge, Yunting Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114415-114415
Open Access | Times Cited: 19

Small-molecule natural plants for reversing liver fibrosis based on modulation of hepatic stellate cells activation: An update
Yu Zheng, Long Xie, Dejun Yang, et al.
Phytomedicine (2023) Vol. 113, pp. 154721-154721
Closed Access | Times Cited: 18

N6-methyladenosine-modified circIRF2, identified by YTHDF2, suppresses liver fibrosis via facilitating FOXO3 nuclear translocation
Xin Chen, Sai Zhu, Hai-Di Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 248, pp. 125811-125811
Closed Access | Times Cited: 18

Signaling pathways activated and regulated by stem cell-derived exosome therapy
Ding Li, Danni Li, Zhao Wang, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7

Structural and Temporal Dynamics of Mesenchymal Stem Cells in Liver Diseases From 2001 to 2021: A Bibliometric Analysis
Bo Shao, Yafei Qin, Shaohua Ren, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26

Circular RNAs Acting as miRNAs’ Sponges and Their Roles in Stem Cells
Juan Xiao, Shija Joseph, Mengwei Xia, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 10, pp. 2909-2909
Open Access | Times Cited: 23

Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Agent for the Treatment of Liver Diseases
Yi� Ding, Qiulin Luo, Hanyun Que, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10972-10972
Open Access | Times Cited: 23

Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
Le Li, Zhijun Zhu
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 15

Circular RNAs with protein-coding ability in oncogenesis
Jiahui Cheng, Guangyue Li, Wenmeng Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188909-188909
Closed Access | Times Cited: 15

Proangiogenic role of circRNA ‐007371 in liver fibrosis
Chong Zhao, Shuaijie Qian, Yang Tai, et al.
Cell Proliferation (2023) Vol. 56, Iss. 6
Open Access | Times Cited: 14

Page 1 - Next Page

Scroll to top